NCT01336920 Carfilzomib in Treating Patients With Relapsed or Refractory T-Cell Lymphoma Status COMPLETED Phase PHASE1
NCT01331941 A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function Status COMPLETED Phase PHASE1
NCT01328171 FOLFOXIRI With or Without Panitumumab in Metastatic Colorectal Cancer (VOLFI) Status COMPLETED Phase PHASE2
NCT01327612 Open Label Extension Study of Conatumumab and Ganitumab (AMG 479) Status COMPLETED Phase PHASE2
NCT01325194 CHemoImmunotherapy With Early Central Nervous System (CNS) Prophylaxis Status COMPLETED Phase PHASE2
NCT01313884 Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma Status TERMINATED Phase PHASE2
NCT01313221 Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT01313208 Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel) Status COMPLETED Phase PHASE4
NCT01312857 Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal Cancer Status COMPLETED Phase PHASE2
NCT01312493 Selective IMRT for Locally Advanced Head and Neck Carcinoma With Concurrent Panitumumab Status WITHDRAWN Phase PHASE2
NCT01308840 Gemcitabine, Oxaliplatin and Panitumumab in Kras/B-raf Wild-Type Biliary Track and Gallbladder Cancer Status COMPLETED Phase PHASE2
NCT01307423 Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA) Status COMPLETED Phase PHASE3
NCT01305772 Identification of Gene Expression Signature for Panitumumab Sensitivity in Untreated Locally Advanced SCCHN Status TERMINATED Phase PHASE2
NCT01302392 A Study of Carfilzomib vs Best Supportive Care in Subjects With Relapsed and Refractory Multiple Myeloma Status COMPLETED Phase PHASE3
NCT01300208 To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus Status COMPLETED Phase PHASE2
NCT01294397 Effects of Denosumab on the Pharmacokinetics of Etanercept Status TERMINATED Phase PHASE1
NCT01290042 Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181. Status COMPLETED Phase PHASE1